MorphoSys AG (MOR) Q4 2020 Earnings Conference Call March 16, 2021 9:00 AM ET
Company Participants
Julia Neugebauer - Director, IR
Jean-Paul Kress - CEO
Roland Wandeler - COO
Malte Peters - Chief R&D Officer
Sung Lee - CFO
Conference Call Participants
Geoffrey Porges - SVB Leerink
James Gordon - JPMorgan
Graig Suvannavejh - Goldman Sachs
James Quigley - Morgan Stanley
Vineet Agrawal - Citibank
Paul Jeng - Guggenheim Securities
Zhiqiang Shu - Berenberg
Jason Butler - JMP Securities
Operator
Ladies and gentlemen, welcome to the MorphoSys Year End 2020 Conference Call. Please note that for the duration of the presentation, all participants will be in listen-only mode, and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. [Operator Instructions]
Now, I would like to turn the conference over to you, Dr. Julia Neugebauer. Please go ahead.
Julia Neugebauer
Ladies and gentlemen, good afternoon and good morning. My name is Julia Neugebauer, Senior Director, Investor Relations at MorphoSys. And it's my pleasure to welcome you to our fourth quarter and full-year 2020 financial results conference call. Joining me on the call today are Jean-Paul Kress, Chief Executive Officer; Sung Lee, Chief Financial Officer; Roland Wandeler, Chief Operating Officer; and Malte Peters, Chief Research and Development Officer.
A press release was issued yesterday, with our full-year 2020 financial results and business update. This can be found on our Web site, along with the presentation for today's webcast.
Before we begin, I'd like to remind you, on slide two, that some of the statements made during the call today are forward-looking statements, including statements regarding our expectations for the commercialization of our products and our development plans, the impact of COVID-19 on our business, and expectations for the compounds in our pipeline, as well as the development plans of our collaboration partners. These
- Read more current MOR analysis and news
- View all earnings call transcripts